18 June 2013
Keywords: zeneca, tomudex, launched, first, market, several, months
Article | 11 March 1996
Several months later than expected, Zeneca has launched Tomudex (raltitrexed), the first single-agent cytotoxic for the first-line palliative treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.